Skip to main navigation Skip to search Skip to main content

Exploring the utility of serum anti-tNASP antibodies as a screening biomarker in prostate, pancreatic, and ovarian cancer

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalAnnals of Oncology
Volume34
DOIs
StatePublished - Oct 1 2023

Disciplines

  • Oncology

Cite this